Suppr超能文献

用于月骨缺损修复的含骨间充质干细胞外泌体的Bgh/甲基丙烯酰化明胶/羧甲基壳聚糖水凝胶

Bgh/GelMA/CMCS hydrogel with bone MSC-EVs for lunate defect repair.

作者信息

Li Miaozhong, Hu Haoliang, Liu Linhai, Tian Mintao, Li Xueyuan

机构信息

Hand Surgery Department, Ningbo NO.6 hospital, Ningbo, China.

Hand Surgery Department, Shanghai Tenth People's Hospital, Shanghai, China.

出版信息

Nanomedicine (Lond). 2025 Aug;20(15):1835-1850. doi: 10.1080/17435889.2025.2513852. Epub 2025 Jun 30.

Abstract

PURPOSE

Kienböck disease, characterized by avascular necrosis of the lunate bone, remains difficult to treat. This study developed a 3D-printed Bgh/GelMA/CMCS (BGC) hydrogel scaffold loaded with bone mesenchymal stem cells (MSC-EVs) for lunate bone repair.

METHOD

MSC-EVs were isolated using ultracentrifugation, and incorporated into BGC lunate-like scaffolds via 3D-printing. Scaffold properties, including surface morphology, biomechanical strength, degradation, and EV release, were investigated. Rabbit lunate defects were treated with these hydrogel scaffolds, and their structure and stability were evaluated. Inflammation, neovascularization, and bone generation were analyzed.

RESULTS

The BGC hydrogel scaffold loaded with MSC-EVs maintained bioactivity with excellent biocompatibility and stability, releasing EVs slowly over a month. In vitro, EVs@BGC hydrogel promoted HUVEC and BMSC proliferation, migration, and tube formation. In vivo, the M1/M2 ratio and inflammatory factors decreased significantly one-week post-implantation, while CD31 and VEGF-positive cells increased at four weeks, and BMP2 and OPN-positive cells at eight weeks. HE staining and Masson's trichrome showed better bone generation in the EVs@BGC group.

CONCLUSIONS

The EVs@BGC lunate-like hydrogel scaffold provides structural support and sustained MSC-EV release, reducing early inflammation and enhancing neovascularization and bone formation over time.

摘要

目的

月骨无菌性坏死所导致的Kienböck病仍然难以治疗。本研究开发了一种负载骨髓间充质干细胞外泌体(MSC-EVs)的3D打印Bgh/GelMA/CMCS(BGC)水凝胶支架用于月骨修复。

方法

采用超速离心法分离MSC-EVs,并通过3D打印将其整合到BGC月骨样支架中。研究了支架的性能,包括表面形态、生物力学强度、降解和外泌体释放。用这些水凝胶支架治疗兔月骨缺损,并评估其结构和稳定性。分析炎症、新生血管形成和骨生成情况。

结果

负载MSC-EVs的BGC水凝胶支架保持生物活性,具有良好的生物相容性和稳定性,在一个多月的时间里缓慢释放外泌体。在体外,EVs@BGC水凝胶促进人脐静脉内皮细胞(HUVEC)和骨髓间充质干细胞(BMSC)的增殖、迁移和管腔形成。在体内,植入后一周M1/M2比率和炎症因子显著降低,四周时CD31和血管内皮生长因子(VEGF)阳性细胞增加,八周时骨形态发生蛋白2(BMP2)和骨桥蛋白(OPN)阳性细胞增加。苏木精-伊红(HE)染色和Masson三色染色显示EVs@BGC组骨生成更好。

结论

EVs@BGC月骨样水凝胶支架提供结构支撑并持续释放MSC-EVs,减少早期炎症,并随着时间的推移增强新生血管形成和骨形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f35/12320810/aec834896080/INNM_A_2513852_F0001_OC.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验